UK Urged To Take Lead on Novel Clinical Trials, Foster Digital Tools
Executive Summary
With Brexit looming, the UK life sciences industry has called on the government to do more to bolster the country’s ability to attract clinical trials, particularly those with novel designs. It has also proposed a “translational fund” to support the pre-commercial creation of “clinically-useable” products.